Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in middle age. Incidence rate of acute myeloid leukemia is high in men and women over 50 years.
The report details the trend, potential and market size of Acute Myeloid Leukemia Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Acute Myeloid Leukemia Therapeuticsmarket, defines the market attractiveness level of Acute Myeloid Leukemia Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Acute Myeloid Leukemia Therapeutics industry, describes the types of Acute Myeloid Leukemia Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Acute Myeloid Leukemia Therapeutics market and the development prospects and opportunities of Acute Myeloid Leukemia Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Acute Myeloid Leukemia Therapeutics market in Chapter 13.
By Player:
Sanofi SA
Abbvie Inc
Pfizer Inc
Teva Pharmaceutical
Takeda
Gilead Sciences Inc
Bristol-Myers Squibb Company
Amgen Inc
Novartis AG
Roche Holding AG
Celgene
By Type:
Pipeline Drugs
Chemotherapy Drugs
Chemotherapy Regimens
By End-User:
Hospitals
Clinics
Home Care
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Acute Myeloid Leukemia Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Acute Myeloid Leukemia Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Acute Myeloid Leukemia Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Acute Myeloid Leukemia Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Acute Myeloid Leukemia Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Acute Myeloid Leukemia Therapeutics Consumption (2017-2022)
-
7.2 United States Acute Myeloid Leukemia Therapeutics Consumption (2017-2022)
-
7.3 Europe Acute Myeloid Leukemia Therapeutics Consumption (2017-2022)
-
7.4 China Acute Myeloid Leukemia Therapeutics Consumption (2017-2022)
-
7.5 Japan Acute Myeloid Leukemia Therapeutics Consumption (2017-2022)
-
7.6 India Acute Myeloid Leukemia Therapeutics Consumption (2017-2022)
-
7.7 South Korea Acute Myeloid Leukemia Therapeutics Consumption (2017-2022)
8 Region and Country-wise Acute Myeloid Leukemia Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Acute Myeloid Leukemia Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Acute Myeloid Leukemia Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Acute Myeloid Leukemia Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Acute Myeloid Leukemia Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Acute Myeloid Leukemia Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Acute Myeloid Leukemia Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Acute Myeloid Leukemia Therapeutics Consumption Forecast (2022-2028)
9 Global Acute Myeloid Leukemia Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Acute Myeloid Leukemia Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Pipeline Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Chemotherapy Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Chemotherapy Regimens Consumption and Growth Rate (2017-2022)
-
9.2 Global Acute Myeloid Leukemia Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Home Care Consumption and Growth Rate (2017-2022)
10 Global Acute Myeloid Leukemia Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Acute Myeloid Leukemia Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Pipeline Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Chemotherapy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Chemotherapy Regimens Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Acute Myeloid Leukemia Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Home Care Consumption Forecast and Growth Rate (2022-2028)
11 Global Acute Myeloid Leukemia Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Acute Myeloid Leukemia Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Acute Myeloid Leukemia Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Acute Myeloid Leukemia Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Acute Myeloid Leukemia Therapeutics Market Competitive Analysis
-
14.1 Sanofi SA
-
14.1.1 Sanofi SA Company Details
-
14.1.2 Sanofi SA Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi SA Acute Myeloid Leukemia Therapeutics Product and Service
-
14.2 Abbvie Inc
-
14.2.1 Abbvie Inc Company Details
-
14.2.2 Abbvie Inc Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Abbvie Inc Acute Myeloid Leukemia Therapeutics Product and Service
-
14.3 Pfizer Inc
-
14.3.1 Pfizer Inc Company Details
-
14.3.2 Pfizer Inc Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Inc Acute Myeloid Leukemia Therapeutics Product and Service
-
14.4 Teva Pharmaceutical
-
14.4.1 Teva Pharmaceutical Company Details
-
14.4.2 Teva Pharmaceutical Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Teva Pharmaceutical Acute Myeloid Leukemia Therapeutics Product and Service
-
14.5 Takeda
-
14.5.1 Takeda Company Details
-
14.5.2 Takeda Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Takeda Acute Myeloid Leukemia Therapeutics Product and Service
-
14.6 Gilead Sciences Inc
-
14.6.1 Gilead Sciences Inc Company Details
-
14.6.2 Gilead Sciences Inc Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Gilead Sciences Inc Acute Myeloid Leukemia Therapeutics Product and Service
-
14.7 Bristol-Myers Squibb Company
-
14.7.1 Bristol-Myers Squibb Company Company Details
-
14.7.2 Bristol-Myers Squibb Company Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb Company Acute Myeloid Leukemia Therapeutics Product and Service
-
14.8 Amgen Inc
-
14.8.1 Amgen Inc Company Details
-
14.8.2 Amgen Inc Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Amgen Inc Acute Myeloid Leukemia Therapeutics Product and Service
-
14.9 Novartis AG
-
14.9.1 Novartis AG Company Details
-
14.9.2 Novartis AG Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis AG Acute Myeloid Leukemia Therapeutics Product and Service
-
14.10 Roche Holding AG
-
14.10.1 Roche Holding AG Company Details
-
14.10.2 Roche Holding AG Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Roche Holding AG Acute Myeloid Leukemia Therapeutics Product and Service
-
14.11 Celgene
-
14.11.1 Celgene Company Details
-
14.11.2 Celgene Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Celgene Acute Myeloid Leukemia Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Acute Myeloid Leukemia Therapeutics
-
Figure Acute Myeloid Leukemia Therapeutics Picture
-
Table Global Acute Myeloid Leukemia Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Acute Myeloid Leukemia Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Acute Myeloid Leukemia Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Acute Myeloid Leukemia Therapeutics Consumption by Country (2017-2022)
-
Figure United States Acute Myeloid Leukemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Acute Myeloid Leukemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Acute Myeloid Leukemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Acute Myeloid Leukemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Acute Myeloid Leukemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Acute Myeloid Leukemia Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Acute Myeloid Leukemia Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Acute Myeloid Leukemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Acute Myeloid Leukemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Acute Myeloid Leukemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Acute Myeloid Leukemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Acute Myeloid Leukemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Acute Myeloid Leukemia Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pipeline Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Regimens Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Home Care Consumption and Growth Rate (2017-2022)
-
Figure Global Pipeline Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Regimens Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Care Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Acute Myeloid Leukemia Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Acute Myeloid Leukemia Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi SA (Foundation Year, Company Profile and etc.)
-
Table Sanofi SA Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Acute Myeloid Leukemia Therapeutics Product and Service
-
Table Abbvie Inc (Foundation Year, Company Profile and etc.)
-
Table Abbvie Inc Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvie Inc Acute Myeloid Leukemia Therapeutics Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Acute Myeloid Leukemia Therapeutics Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Acute Myeloid Leukemia Therapeutics Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Acute Myeloid Leukemia Therapeutics Product and Service
-
Table Gilead Sciences Inc (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Inc Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Inc Acute Myeloid Leukemia Therapeutics Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Acute Myeloid Leukemia Therapeutics Product and Service
-
Table Amgen Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen Inc Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc Acute Myeloid Leukemia Therapeutics Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Acute Myeloid Leukemia Therapeutics Product and Service
-
Table Roche Holding AG (Foundation Year, Company Profile and etc.)
-
Table Roche Holding AG Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Holding AG Acute Myeloid Leukemia Therapeutics Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Acute Myeloid Leukemia Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Acute Myeloid Leukemia Therapeutics Product and Service
-
